BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5511394)

  • 1. [The importance of Vi- and O-antigens for formation of immunity to typhoid infections].
    Kolobova LF; Pershin BB
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):97-101. PubMed ID: 5511394
    [No Abstract]   [Full Text] [Related]  

  • 2. [The experimental basis of various problems in enteral vaccination. 2. Effectiveness of Vi- and O-antigen typhoid vaccines when used enterally].
    Kovaleva NI; Mironova MV; Khatuntseva NV
    Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):9-13. PubMed ID: 5346282
    [No Abstract]   [Full Text] [Related]  

  • 3. [The experimental basis for several problems in the enteric method of vaccination. I. Immunogenicity of typhoid Vi- and O-antigens in enteric vaccination].
    Kovaleva NI; Khatuntseva NV; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Aug; 45(8):65-71. PubMed ID: 5731442
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typhoid immunisation.
    Ghai OP; Paul VK
    Indian J Pediatr; 1984; 51(408):71-6. PubMed ID: 6378786
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously.
    Mohandas V; Cherian T; Sridharan G; Simoes EA; Pereira SM; John TJ
    BMJ; 1989 Jan; 298(6667):162-3. PubMed ID: 2493838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Typhoid vaccination from an immunological point of view].
    Günther O
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)].
    Krasnoproshina LI
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with typhoid vaccine in Thailand.
    Sarasombath S
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):471-4. PubMed ID: 3064324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of the typhoid immunity along one year after intradermal vaccination.
    Dimache G; Croitoru M; Ciordaş C; Velea V
    Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of typhoid fever.
    Levine MM; Lepage P
    Adv Exp Med Biol; 2005; 568():161-73. PubMed ID: 16107071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 15. [General immune reactions in man following oral administration of acetone-inactivated typhoid vaccines. II].
    Karolcek J; Draskovicová M; Greorch D; Mikulková V; Luzová D
    Zentralbl Bakteriol Orig; 1969; 211(4):502-10. PubMed ID: 4916992
    [No Abstract]   [Full Text] [Related]  

  • 16. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a Vi-degrading enzyme on potency of typhoid vaccines in mice.
    Wong KH; Feeley JC; Pittman M
    J Infect Dis; 1972 Apr; 125(4):360-6. PubMed ID: 4553079
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Ground in Malawi-First Typhoid Conjugate Vaccine Study in Africa.
    Patel P; Patel P; Meiring JE; Misiri T; Mwakiseghile F; Gordon MA
    Am J Trop Med Hyg; 2019 Jun; 100(6):1299-1300. PubMed ID: 31190683
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.